Maryam Riyadh Yaseen Al-bayati1, Nazih Shaban Mustafa2, Basma Ezzat Mustafa1*, Khairani Idah Mokhtar1, Muhammad Salahuddin Haris3
1. Department of Fundamental Dental and Medical Sciences, Faculty of Dentistry, International Islamic University, Jalan Sultan Ahmad Shah, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia.
2. Department of Oral Maxillofacial Surgery and Oral Diagnosis, Faculty of Dentistry, International Islamic University, Jalan Sultan Ahmad Shah, Bandar Indera Mahkota, 25200 Kuantan, Pahang, Malaysia.
3. Department of Pharmacy, Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, University of Kuala Lumpur, Jalan Greentown, 30450 Ipoh, Perak, Malaysia.
*Corresponding author: Basma Ezzat Mustafa Al-Ahmad.
ABSTRACT
INTRODUCTION: Oral mucosal lesions, such as aphthous ulcers, oral lichen planus, and chemotherapy-induced mucositis, are painful conditions that significantly impair patients’ quality of life. Current therapies often yield limited effectiveness or undesirable side effects. Tualang honey (TH), a Malaysian wild honey, exhibits strong antimicrobial, anti-inflammatory, and wound-healing properties, making it a promising natural therapeutic agent. However, maintaining its retention and bioactivity in the oral cavity remains challenging.
OBJECTIVE: To develop a stable biocarrier-based system incorporating TH to enhance the delivery and retention for the treatment of oral mucosal lesions.
MATERIALS & METHODS: The total phenolic content (TPC) of TH was determined using the Folin-Ciocalteu spectrophotometric method, while its antioxidant capacity was assessed via 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay. In vitro cytotoxicity was evaluated in human primary gingival fibroblasts using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. TH was loaded into a hydrogel formulation, and its physical properties—including pH, spreadability, viscosity, and homogeneity—were characterised.
RESULTS: In this study, TH demonstrated a high TPC (207.32 ± 16.38 mg GAE/100 g) and substantial antioxidant activity with a half-maximal inhibitory concentration (IC₅₀) value of 34.92 ± 3.23 µg/mL, supporting its therapeutic relevance. Its cytotoxicity was both concentration- and time-dependent, with an IC₅₀ of 5.860 ± 0.92 mg/mL at 24 hours and 9.36 ± 0.18 mg/mL at 48 hours. TH hydrogel was prepared using 2% xanthan gum with high viscosity at low shear, stable pH, adequate spreadability, and physical homogeneity without signs of phase separation.
CONCLUSION: TH-infused hydrogel biocarrier systems present a promising natural therapeutic approach for managing oral mucosal lesions. These formulations enhance honey’s retention at lesion sites, supporting faster and more effective healing.
KEYWORDS: Tualang Honey, Oral Mucosal Lesions, Biocarrier, Natural Therapy


